Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells

Oncology Letters

Volumn 6, Issue 5, 2013, Pages 1435-1438

  Chang, Ken Hu ^a   Yan, Ming De ^b   Yao, Chih Jung ^b   Lin, Pei Chun ^b   Lai, Gi Ming ^b,c  

^a Taipei Medical Universtiy Shuang Ho Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Apoptosis; Autophagy; Glioblastoma multiforme; Honokiol

Indexed keywords

BECLIN 1; HONOKIOL; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL XL; RETINOBLASTOMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL CYCLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84884476892     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1548     Document Type: Article

References (25)

1. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, CaveneeWK and DePinho RA: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333, 2001.
2. Morandi E, Severini C, Quercioli D, D'Ario G, PerdichizziS, Capri M, Farruggia G, Mascolo MG, Horn W, Vaccari M, SerraR, Colacci A and Silingardi P: Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines. Mol Cancer 7: 66, 2008.
3. Chang LF, Lin PC, Ho LI, Liu PY, Wu WC, Chiang IP, ChangHW, Lin SZ, Harn YC, Harn HJ and Chiou TW: Overexpression of the orphan receptor Nur77 and its translocation induced by PCH4 may inhibit malignant glioma cell growth and induce cell apoptosis. J Surg Oncol 103: 442-450, 2011.
4. Long JS and Ryan KM: New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 31: 5045-5060, 2012.
5. Torres S, Lorente M, Rodríguez-Fornés F, Hernández-TiedraS, Salazar M, García-Taboada E, Barcia J, Guzmán M and VelascoG: A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther 10: 90-103, 2011.
6. Hahm ER, Arlotti JA, Marynowski SW and Singh SV: Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14: 1248-1257, 2008.
7. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, DubielW, Soff G and Arbiser JL: Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278: 35501-35507, 2003.
8. Munroe ME, Arbiser JL and Bishop GA: Honokiol, a natural plant product, inhibits inflammatory signals and alleviates inflammatory arthritis. J Immunol 179: 753-763, 2007.
9. Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, KimJ and Park D: In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 496: 189-195, 2004.
10. Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S and Hu X: Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. World J Gastroenterol 10: 3459-3463, 2004.
11. Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S and HuX: Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol10: 2205-2208, 2004.
12. Konoshima T, Kozuka M, Tokuda H, Nishino H, Iwashima A, Haruna M, Ito K and Tanabe M: Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. JNat Prod 54: 816-822, 1991.
13. Xu D, Lu Q and Hu X: Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280, 2006.
14. Wang X, Duan X, Yang G, Zhang X, Deng L, Zheng H, Deng C, WenJ, Wang N, Peng C, Zhao X, Wei Y and Chen L: Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. PLoS One 6: e18490, 2011.
15. Chilampalli S, Zhang X, Fahmy H, Kaushik RS, ZemanD, Hildreth MB and Dwivedi C: Chemopreventive effects of honokiol on UVB-induced skin cancer development. Anticancer Res 30: 777-783, 2010.
16. Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L and WeiY: Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells. Eur J Obstet Gynecol Reprod Biol 140: 95-102, 2008.
17. Battle TE, Arbiser J and Frank DA: The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106: 690-697, 2005.
18. Chau BN and Wang JY: Coordinated regulation of life and death by RB. Nat Rev Cancer 3: 130-138, 2003.
19. Fujita N, Nagahashi A, Nagashima K, Rokudai S and TsuruoT: Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 17: 1295-1304, 1998.
20. Itoh M, Chiba H, Noutomi T, Takada E and Mizuguchi J: Cleavage of Bax-alpha and Bcl-x(L) during carboplatin-mediated apoptosis in squamous cell carcinoma cell line. Oral Oncol36: 277-285, 2000.
21. Lefranc F, Facchini V and Kiss R: Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12: 1395-1403, 2007.
22. Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, LaharanneE, Véron N, Vital A, Loiseau H, Merlio JP and BellocF: Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biol Ther 11: 1017-1027, 2011.
23. Kang R, Zeh HJ, Lotze MT and Tang D: The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 18: 571-580, 2011.
24. Wu WK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FK, YuJ and Sung JJ: The autophagic paradox in cancer therapy. Oncogene 31: 939-953, 2012.
25. Chen N and Karantza V: Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157-168, 2011.